LAUSR

Sacral colpopexy, a surgical treatment for middle compartment defects, connects the uterus or the top of the vagina with the sacral anterior longitudinal ligament by bridging grafts. It is currently the recognized gold standard of prolapse surgery,[1] with a long‐term success rate of 74–98%. It is suitable for patients with uterine prolapse or Stage II–IV vaginal vault prolapse and recurrence after the operation,[2,3] particularly for younger patients who are sexually active. In the present article, we analyzed the clinical and follow‐up data of 204 patients (mean age: 59.7 ± 8.8 years, range: 40–75 years) who underwent laparoscopic sacral colpopexy (LSC) treatment for pelvic organ prolapse (POP) in the Second Hospital of Shandong University from January 2012 to June 2015.